ARCHIVES

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

U.S., France Offer Carcinogenesis Program

February 13, 1981

NIH selects nine scientists for Pioneer Awards.

October 1, 2004

Varmus, In Letter To Institute Pasteur, Reopens Discussion Of Test Kit Royalties

July 1, 1994

Revised Price Equivalent to Lower Dose of Avastin

November 8, 2012

Preventive Ovarian Surgery Recommended For Women with BRCA1 Mutations by Age 35

February 28, 2014

NCI Cooperative Group Clinical Trials Approved

May 29, 2009